» Articles » PMID: 25362178

Compartmentalization of Simian Immunodeficiency Virus Replication Within Secondary Lymphoid Tissues of Rhesus Macaques is Linked to Disease Stage and Inversely Related to Localization of Virus-specific CTL

Abstract

We previously demonstrated that HIV replication is concentrated in lymph node B cell follicles during chronic infection and that HIV-specific CTL fail to accumulate in large numbers at those sites. It is unknown whether these observations can be generalized to other secondary lymphoid tissues or whether virus compartmentalization occurs in the absence of CTL. We evaluated these questions in SIVmac239-infected rhesus macaques by quantifying SIV RNA(+) cells and SIV-specific CTL in situ in spleen, lymph nodes, and intestinal tissues obtained at several stages of infection. During chronic asymptomatic infection prior to simian AIDS, SIV-producing cells were more concentrated in follicular (F) compared with extrafollicular (EF) regions of secondary lymphoid tissues. At day 14 of infection, when CTL have minimal impact on virus replication, there was no compartmentalization of SIV-producing cells. Virus compartmentalization was diminished in animals with simian AIDS, which often have low-frequency CTL responses. SIV-specific CTL were consistently more concentrated within EF regions of lymph node and spleen in chronically infected animals regardless of epitope specificity. Frequencies of SIV-specific CTL within F and EF compartments predicted SIV RNA(+) cells within these compartments in a mixed model. Few SIV-specific CTL expressed the F homing molecule CXCR5 in the absence of the EF retention molecule CCR7, possibly accounting for the paucity of F CTL. These findings bolster the hypothesis that B cell follicles are immune privileged sites and suggest that strategies to augment CTL in B cell follicles could lead to improved viral control and possibly a functional cure for HIV infection.

Citing Articles

Compartmental structure in the secondary lymphoid tissue can slow down HIV-1 evolution in the presence of strong CTL responses.

Chung W, Wodarz D J R Soc Interface. 2025; 22(223):20240468.

PMID: 39999881 PMC: 11858754. DOI: 10.1098/rsif.2024.0468.


Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence.

Varco-Merth B, Chaunzwa M, Duell D, Marenco A, Goodwin W, Dannay R PLoS Pathog. 2024; 20(8):e1012496.

PMID: 39173097 PMC: 11373844. DOI: 10.1371/journal.ppat.1012496.


Delivering CRISPR to the HIV-1 reservoirs.

Gurrola T, Effah S, Sariyer I, Dampier W, Nonnemacher M, Wigdahl B Front Microbiol. 2024; 15():1393974.

PMID: 38812680 PMC: 11133543. DOI: 10.3389/fmicb.2024.1393974.


Human immunodeficiency virus dynamics in secondary lymphoid tissues and the evolution of cytotoxic T lymphocyte escape mutants.

Chung W, Connick E, Wodarz D Virus Evol. 2024; 10(1):vead084.

PMID: 38516655 PMC: 10956502. DOI: 10.1093/ve/vead084.


Immunotherapy-induced cytotoxic T follicular helper cells reduce numbers of retrovirus-infected reservoir cells in B cell follicles.

Malyshkina A, Bayer W, Podschwadt P, Otto L, Karakoese Z, Sutter K PLoS Pathog. 2023; 19(10):e1011725.

PMID: 37883584 PMC: 10602292. DOI: 10.1371/journal.ppat.1011725.


References
1.
Pantaleo G, Graziosi C, Demarest J, Butini L, Montroni M, Fox C . HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature. 1993; 362(6418):355-8. DOI: 10.1038/362355a0. View

2.
Cubas R, Mudd J, Savoye A, Perreau M, van Grevenynghe J, Metcalf T . Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat Med. 2013; 19(4):494-9. PMC: 3843317. DOI: 10.1038/nm.3109. View

3.
Embretson J, Zupancic M, Ribas J, Burke A, Racz P, Tenner-Racz K . Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature. 1993; 362(6418):359-62. DOI: 10.1038/362359a0. View

4.
Elahi S, Niki T, Hirashima M, Horton H . Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection. Blood. 2012; 119(18):4192-204. PMC: 3359739. DOI: 10.1182/blood-2011-11-389585. View

5.
Koenig S, Conley A, Brewah Y, Jones G, Leath S, Boots L . Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat Med. 1995; 1(4):330-6. DOI: 10.1038/nm0495-330. View